Safety study of a new heart stent design
Part of Heart & circulation clinical trials.
This study tracks how well a newer heart stent (a small metal tube that keeps arteries open) works in real patients. Researchers want to understand if this specific stent design is safe and effective over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a heart procedure at Geneva University Hospitals between January 2021 and December 2025 where this stent was placed
- You can read and understand French, German, English, or Italian
- You are able and willing to sign a consent form
- You do not have a serious non-heart illness that would limit your life to less than 12 months
- You are reachable by phone or mail for follow-up conversations
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests a new stent system for treating narrowed heart arteries. If you have coronary artery disease with one or two blockages that are at least 70% narrowed, this procedure might be an option for you.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This trial tests a longer-than-usual drug-coated stent (Orsiro Mission) for treating long blockages in heart arteries. It aims to see if the stent is safe and effective for people with coronary artery disease.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.